Journal of Clinical and Experimental Nephrology

, Volume 8, Issue 3, pp 178–182 | Cite as

Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage



Recently, a novel endothelial oxidized low-density lipoprotein (LDL) receptor, lectin-like oxidized LDL receptor (LOX)-1, has been identified by the expression cloning of cultured bovine aortic endothelial cells (BAEC). The experimental evidence has suggested that LOX-1 may contribute to the development of vascular injury. For example, LOX-1 is upregulated in aorta from hypertensive, diabetic, and hyperlipidemic model animals. Also, LOX-1 overexpression is observed in atherosclerotic regions and damaged kidneys. In hypertensive animals, not only antihypertensive drugs but also antioxidant agents suppress the LOX-1 overexpression. Peroxisome proliferator-activated receptor-γ (PPARγ) activators inhibit cytokine-stimulated LOX-1 expression, possibly through their antioxidant effects, while, in contrast, LOX-1 generates reactive oxygen species (ROS). Therefore, ROS may play an important role in both the expression and function of LOX-1.

Key words

Mechanical stress Oxidative stress Endothelium Angiotensin II Glomerulosclerosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Japanese Society of Nephrology 2004

Authors and Affiliations

  1. 1.Department of Nephrology and EndocrinologyUniversity of Tokyo School of MedicineTokyoJapan

Personalised recommendations